Other Content
WELCOME!
Wake Forest University Health Sciences, in collaboration with the Brigham and Women's Hospital, a Teaching Affiliate of Harvard Medical School, has established a NIH funded Center for Botanical Lipids. The central objective for this new research Center is to determine the safety and effectiveness of fatty acid-based dietary supplements for the prevention and treatment of chronic inflammatory diseases such as atherosclerosis and asthma.
Central Objective of Center:
The central objective of the Center for Botanical Lipids at Wake Forest University School of Medicine is to test and determine the mechanistic basis of action, the safety, and the efficacy for fatty acid-based dietary supplements for the prevention and treatment of chronic human diseases associated with inflammation.
Lipid mediators of inflammation and disease. An important mediator of inflammation and human disease is arachidonic acid (AA), a polyunsaturated fatty acid derived from our diets (Figure 1) that is found in the membranes of all cells, including those of the immune system.

Stimulated during inflammation, arachidonic acid can be transformed into inflammatory messengers known as prostaglandins and leukotrienes, which can be key drivers of inflammation (see Figure 2). Free arachidonic acid may be metabolized by 5-lipoxygenase (5-LO) to leukotrienes, or by one of the two types of enzymes known as cyclooxygenase, (COX I or COX II) to form prostaglandins and thromboxanes.

Leukotrienes, prostaglandins and thromboxanes have been implicated in diverse physiological processes, including asthma, inflammation, carcinogenesis, hemostasis, parturition, maintenance of renal function, pain and fever. Given of the central importance of this pathway to health and disease, over $10 billion per year is spent by consumers to block various inflammatory mediators in the pathway and their resulting effects on signs and symptoms of disease. Most inhibitors provide some relief, but side effects may be problematic (aspirin and ibuprofen irritate the stomach, some COX 2 inhibitors appear to have adverse vascular effects). Consequently, there is significant interest in finding other approaches to managing these diseases and symptoms.
Dietary manipulation of inflammatory lipids. Since AA is derived from dietary lipids (see Figure 1) and it is of central importance to human disease, there has also been a large research effort over the last 20 years to determine how production of these important inflammatory substances can be controlled by dietary manipulation. As detailed in Figure 3, dietary linoleic acid is a primary source of n-6 fatty acids in human diets and its conversion to AA is tightly controlled by limiting the
-5 and
-6 desaturation enzyme steps. All projects in the Center for Botanical Lipids focus on botanical fatty acids in this one specific pathway involving the elongation and desaturation of n-3 and n-6 fatty acids (see Figure 3).

The left side of the figure shows the pathway by which dietary linoleic acid (LA), the initial member of the n-6 family of fatty acids, can be transformed to AA. The right side of the pathway shows how a-linolenic acid, the initial member of the n-3 pathway, is converted to eicosapentaenoic acid (EPA). EPA and another member of the n-3 family, docosahexaenoic acid (DHA) are fatty acids found in high concentrations in marine oils that have been shown to have health benefits. These fatty acids have been demonstrated to inhibit the conversion of AA to several mediators of inflammation. These fatty acids can also be converted to natural receptor antagonists that compete with AA products. Both of these processes are thought to attenuate inflammatory responses in a variety of diseases. Additionally these marine fatty acids have been shown to be highly effective in reducing atherosclerosis and hypertriglyceridemia in a variety of conditions. In spite of the beneficial effects of marine oils, the consumption of n-3 fatty acids in the North American population is low.
The key question that this Center addresses is: Are there botanical fatty acids in the n-6 and n-3 pathways that are effective in blocking recognized biochemical pathways in lipid metabolism, thereby reducing inflammatory and hyperlipidemic responses associated with diseases such as asthma and atherosclerosis?
There are three primary botanicals that are the focus of the four projects in the Center. Flax seed oil (Linum usitatissium) contains
-linolenic acid (18:3, n-3), echuim seed oil (Echium Plantagineum) contains stearidonic acid (18:4,n-3) and borage seed oil (Borago officinalis) is rich in gamma linolenic acid (18:3, n-6). Each botanical oil provides a metabolic precursor in the n-3 or n-6 pathways and thus could modify the metabolism of AA by producing EPA and DHA. Figure 3 highlights the points in the n-6 and n-3 pathways where each project focuses on the health benefits of particular botanical seed oil. This attention to one important pathway provides a constant focal point for all projects in the Center. Further details can be found under each project heading.
ABOUT OUR STAFF
![]()
The staff of the Center for Botanical Lipids is comprised of four research laboratories and two cores. The Administrative Core, the Lipid Analytical Core, and the research projects of Dr. Larry Rudel, Dr. John Parks, and Dr. Ski Chilton are housed in the new Biotechnology Research Facility 1 (BRF1), a part of Wake Forest University Health Sciences located in the Piedmont Triad Research Park in downtown Winston-Salem, NC. The research project of Dr. Jonathan Arm's laboratory is located in the Division of Rheumatology Immunology and Allergy at the Brigham and Women's Hospital in Boston.
Drs. Rudel and Parks (Projects 1 and 2) are experts in lipid dysfunctions associated with vascular diseases such as atherosclerosis. Drs. Chilton and Arm are experts in the regulation of lipid mediator generation and their roles in inflammation. The Center combines this expertise to focus on the basic molecular and cellular actions of botanical oil supplements for the prevention and treatment of inflammatory diseases.
The new BRF1 building also houses the Lipid Sciences program of the Department of Pathology and several laboratories of the Department of Physiology and Pharmacology. Consequently, this location combines over 50 years of expertise in lipids and human health and serves as a vital resource for the success and development of new ideas in botanical lipids research.
WEBSITE ACCESS AGREEMENT for THE CENTER OF BOTANICAL LIPIDS & WAKE FOREST HEALTH SCIENCES
NO MEDICAL ADVICE
The information on this Website is provided for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. Nothing on this Website should be used for treating or diagnosing a medical or health condition or for replacing any relationship with your physician or other qualified healthcare provider. The health information furnished on this Website and the interactive responses (if any) furnished by or through, this Website are not intended to or implied to be professional medical advice. You are encouraged to consult other sources and confirm the information contained within this Website. Consult your own physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition. For medical concerns, including decisions about medications and other treatments, you should always consult your physician or other, qualified healthcare professional. In serious cases, seek immediate assistance from emergency personnel. If you have or suspect that you have a medical problem or condition, please contact a physician or other qualified healthcare provider immediately. YOU SHOULD NEVER DISREGARD MEDICAL ADVICE OR DELAY IN SEEKING IT BECAUSE OF SOMETHING YOU HAVE READ ON THIS WEBSITE. No medications, diet supplements or treatments as may be described on this Website should be taken or begun without first consulting your physician or other healthcare provider. No information on this Website should be considered or shall be deemed to be an endorsement or recommendation by Wake Forest University Baptist Medical Center (the Medical Center) of any medication, diet supplements, treatments, products, tests or otherwise.
NO WARRANTIES
The information on this Website is not exhaustive and is provided "AS IS" and without any warranties of any kind, either express or implied. All implied warranties of merchantability and fitness for a particular purpose or use are hereby excluded. Disclaimer of Liability of the Medical Center, if any, for damages (including without limitation liability arising out of tort, strict liability, negligence, contract or patent or copyright infringement) shall not exceed the lesser of (i) the fees paid, if any, to the Medical Center for the particular information or service provided on this Website or (ii) $100. The Medical Center shall not be liable under any theory of indemnity. In no event shall the Medical Center be liable for any damages other than the amount referred to above. All other damages, direct or indirect, special, incidental, consequential or punitive are hereby excluded to the fullest extent permitted by law, even if the Medical Center has been advised of the possibility of such damages.
The Medical Center expressly disclaims and DOES NOT WARRANT that the functioning of this Website will be uninterrupted or error free; that any errors will be corrected; that any information on this Website is complete, accurate (although the Medical Center strives for accuracy), or timely (or will be updated); and that this Website, or the server that makes it available, is or will be free of viruses or other harmful components. You are solely responsible for any damage to your computer system or loss of data that results from downloading any material from this Website.
YOU EXPRESSLY ACKNOWLEDGE AND AGREE THAT THE MEDICAL CENTER, ITS LICENSORS, SUPPLIERS AND BUSINESS PARTNERS (IF ANY) ARE NOT RESPONSIBLE FOR THE RESULTS OF YOUR DECISIONS RESULTING FROM THE USE OF THIS WEBSITE OR THE INFORMATION CONTAINED HEREIN, INCLUDING BUT NOT LIMITED TO, YOUR CHOOSING TO SEEK OR NOT TO SEEK PROFESSIONAL MEDICAL CARE, OR YOUR CHOOSING OR NOT CHOOSING SPECIFIC TREATMENT BASED ON THE INFORMATION ON OR ACCESSED THROUGH THIS WEBSITE.
OFFENSIVE OR EXPLICIT CONTENT
This Website may contain scientific, medical or health information which you may find sexually explicit or otherwise offensive. The information on this Website is meant for adults, or for mature teenagers under parental supervision. The Medical Center accepts no responsibility for such materials. You are solely responsible for compliance with the laws applicable to you where you reside.
DISCLAIMER OF ENDORSEMENT
Links to other websites are provided, if at all, for your convenience only, and should not be considered and shall not be deemed as an endorsement or recommendation by the Medical Center of such other websites or their content. The Medical Center is not responsible for the availability, the content or the damage which may be caused by such other websites.
The Medical Center, its licensors and suppliers (if any) make no representations or warranties as to the satisfaction of government regulations requiring disclosure of information on prescription drug products (if any) with regard to the information contained on, or accessed through, this Website.
AGREEMENT NOT TO ACCESS UNAUTHORIZED SITES
As an additional condition to accessing this Website, you agree not to attempt to gain unauthorized access to any areas of this Website, computer systems or networks connected to this Website.
AGREEMENT NOT TO VIOLATE COPYRIGHT
The materials on our Website are copyrighted and may be downloaded or reprinted for personal, non-commercial use only. Permission to reprint or electronically reproduce any document or graphics in whole or in part, for any other reason is prohibited unless prior written consent is obtained from the Medical Center.
This Agreement is subject to change without notice.
Reprinted from WFUSOM Web Site Access Agreement.
